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Erratum
In the paper 'Plasma and urinary oestrogens in breast cancer
patients on treatment with 4-hydroxyandrostenedione' by
Johannessen et al., Br. J. Cancer (1993), 68, 393-398, Figure
1 and Table II were incorrect.




Figure 1 Individual plasma levels of oestradiol (P-Oe2), oestrone
(P-Oe,) and oestrone sulphate (P-Oe,S) before and during treat-
ment in 9 breast cancer patients (8 postmenopausal women: 0,
and I man: *) treated with 250 mg 4-hydroxyandrostenedione
i.m. fortnightly.
Table II Mean values in pmol' 1 (±s.e.m.) and mean percentual suppression
( s.e.m.) of 24 h urinary metabolites before and during treatment with 4-
hydroxyandrostenedione
Metabolite Before During % suppression P
2-OHOel 4.64± 1.47 1.09±0.25 70.8± 5.2 <0.005
4-OHOel 0.54±0.15 0.43±0.12 13.5± 16.0 >0.2
2-OHOe2 2.27± 0.39 1.44±0.37 14.2± 39.2 >0.1
Oe2 1.57±0.27 0.44±0.11 59.7±17.4 <0.025
Oel 5;86± 1.26 1.90±0.35 63.6±5.3 <0.005
2-methoxy0el 1.13±0.22 0.28±0.07 72.9±4.2 <0.005
16a-OHOel 1.91 ±0.26 0.42±0.07 78.1±2.3 <0.005
15a-OHOel 0.35±0.12 0.10±0.02 60.2± 8.2 <0.005
16P-OHOel 1.30±0.33 0.23±0.12 81.8±7.9 <0.005
16-ketoOe2 1.04± 0.17 0.23±0.09 74.3± 9.5 <0.005
Oe3 7.62±1.90 1.92±0.41 68.3±8.3 <0.005
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